Search

Your search keyword '"Bonin, Serena"' showing total 562 results

Search Constraints

Start Over You searched for: Author "Bonin, Serena" Remove constraint Author: "Bonin, Serena"
562 results on '"Bonin, Serena"'

Search Results

1. Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology

4. Baggio–Yoshinari Syndrome: A Report of Five Cases.

6. Evaluation of a New DNA Extraction Method on Challenging Bone Samples Recovered from a WWII Mass Grave

8. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells

10. Comparative Analysis of Gene Expression Analysis Methods for RNA in SituHybridization Images

11. Retrospective Analysis of Potential Lyme Disease Clinical Cases in Argentina.

12. Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study.

15. Unraveling the Complex Nexus of Human Papillomavirus (HPV) in Extragenital Keratinocyte Skin Tumors: A Comprehensive Analysis of Bowen’s Disease and In Situ Squamous-Cell Carcinoma

16. Lyme Disease: A Review with Emphasis on Latin America

19. Giant melanoma of the abdomen: case report and revision of the published cases

24. The history of Lyme disease in Italy and its spread in the Italian territory

30. Supplementary Figure 5 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

31. Supplementary Figure 4 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

32. Supplementary Table 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

33. Supplementary Data from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

34. The Baron Pasquale Revoltella’s Will in the Forensic Genetics Era

35. Supplementary Table 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

36. Supplementary Figure 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

37. Supplementary Figure 2 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

38. Supplementary Table 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

39. Supplementary Figure 6 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

40. Supplementary Figure 3 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy

42. The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

43. Cutaneous melanoma frequencies and seasonal trend in 20 years of observation of a population characterised by excessive sun exposure

Catalog

Books, media, physical & digital resources